What did Wanbury's Tanuku site achieve with the TGA?

It passed a quality inspection from Australia's Therapeutic Goods Administration. The clearance is the penultimate step before receiving a GMP certificate, which would legally permit Wanbury to export APIs to Australia.

Which products will be affected?

Three active pharmaceutical ingredients that are currently not cleared for the Australian market. The filing does not name them.

How does this fit into Wanbury's existing regulatory footprint?

The company already holds a GMP certificate from South Korea's MFDS for its Patalganga site, a milestone disclosed in April 2026. The TGA clearance adds a second major regulatory jurisdiction to its credentials.

What is the significance for a company of Wanbury's size?

With a market capitalisation of ₹913 cr, Wanbury is a micro-cap. Securing clearance from a recognised agency like TGA is a meaningful regulatory milestone that can open new export avenues and is likely material to the company's growth strategy.

Pharmaceuticals · Micro cap

Wanbury clears TGA inspection, nears entry into Australia with three APIs

A successful TGA quality check at Tanuku puts Wanbury one step away from shipping three new active ingredients to Australia. For a ₹913 cr market-cap drugmaker, the regulatory clearance opens a new export market.

— 2 earlier stories on Wanbury Ltd. →

WANBURY By Tipsheet Editorial 10 Jun 2026 · 12:40 PM IST Verify on BSE · NSE

Mkt cap₹911 cr

P/E21.20×

ROE51.51%

Debt / eq.2.92

3 APIs Additional active pharmaceutical ingredients Wanbury can ship to Australia once GMP is granted.

What's new

Wanbury passed TGA's quality inspection at its Tanuku API site in Andhra Pradesh.
A GMP certificate, the next step, would allow exports of three new APIs to Australia.
The company also re-confirmed a prior GMP certificate from South Korea's MFDS for its Patalganga site.

Why this matters

For a micro-cap with a ₹913 cr market capitalisation, landing a TGA inspection pass is a regulatory credential that matters. The agency oversees Australia's therapeutic goods market. Clearing its checks is a prerequisite for market access. The three-API pipeline is small in isolation but represents a new revenue geography for a company that currently ships to other markets.

What we're watching

When Wanbury receives the formal GMP certificate from TGA.
The commercial timeline for the first Australian API shipment.
Whether the new market access moves the needle on Wanbury's export revenue mix.

The full read

Wanbury has passed a quality inspection from Australia's TGA at its API plant in Tanuku. The site is now in line for a GMP certificate, which would unlock exports of 3 new APIs to the Australian market. For a ₹913 cr micro-cap, that is a new revenue geography. The company also reiterated an existing GMP certificate from South Korea's MFDS for its Patalganga facility. Two regulatory wins in short succession. The TGA pass doesn't generate revenue on its own, but it opens a door that was previously closed.

Questions answered

What did Wanbury's Tanuku site achieve with the TGA?: It passed a quality inspection from Australia's Therapeutic Goods Administration. The clearance is the penultimate step before receiving a GMP certificate, which would legally permit Wanbury to export APIs to Australia.
Which products will be affected?: Three active pharmaceutical ingredients that are currently not cleared for the Australian market. The filing does not name them.
How does this fit into Wanbury's existing regulatory footprint?: The company already holds a GMP certificate from South Korea's MFDS for its Patalganga site, a milestone disclosed in April 2026. The TGA clearance adds a second major regulatory jurisdiction to its credentials.
What is the significance for a company of Wanbury's size?: With a market capitalisation of ₹913 cr, Wanbury is a micro-cap. Securing clearance from a recognised agency like TGA is a meaningful regulatory milestone that can open new export avenues and is likely material to the company's growth strategy.

Mentioned: Australia's TGA · Tanuku API site · South Korea's MFDS

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on WANBURY →

10 Jun 2026 · 12:40 PM IST Wanbury clears TGA inspection, nears entry into Australia with three APIs
1d ago Wanbury files for new API markets in Malaysia, Singapore, Korea
8d ago Wanbury's full-year profit jumps 117% on better mix and procurement savings